These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 24827555

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia.
    Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R.
    Schizophr Res; 2007 Jul; 93(1-3):261-5. PubMed ID: 17490859
    [Abstract] [Full Text] [Related]

  • 3. The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.
    Dickerson F, Adamos MB, Katsafanas E, Khushalani S, Origoni A, Savage CLG, Schroeder J, Schweinfurth LAB, Stallings C, Sweeney K, Yolken R.
    Schizophr Res; 2016 Oct; 176(2-3):566-571. PubMed ID: 27262384
    [Abstract] [Full Text] [Related]

  • 4. Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.
    Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R.
    Schizophr Res; 2012 Jan; 134(1):83-8. PubMed ID: 22048011
    [Abstract] [Full Text] [Related]

  • 5. The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia.
    Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Sullens A, Yolken RH.
    Schizophr Res; 2007 Nov; 96(1-3):87-92. PubMed ID: 17601704
    [Abstract] [Full Text] [Related]

  • 6. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia.
    Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH.
    Arch Gen Psychiatry; 2003 May; 60(5):466-72. PubMed ID: 12742867
    [Abstract] [Full Text] [Related]

  • 7. Effects of COMT genotype on cognitive ability and functional capacity in individuals with schizophrenia.
    Twamley EW, Hua JP, Burton CZ, Vella L, Chinh K, Bilder RM, Kelsoe JR.
    Schizophr Res; 2014 Oct; 159(1):114-7. PubMed ID: 25139113
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Dickerson F, Boronow JJ, Stallings C, Origoni AE, Cole SK, Yolken RH.
    Psychiatry Res; 2004 Nov 30; 129(1):45-53. PubMed ID: 15572184
    [Abstract] [Full Text] [Related]

  • 12. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
    Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Leister F, Krivogorsky B, Yolken RH.
    Bipolar Disord; 2006 Apr 30; 8(2):124-32. PubMed ID: 16542182
    [Abstract] [Full Text] [Related]

  • 13. RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings.
    Loughland CM, Lewin TJ, Carr VJ, Sheedy J, Harris AW.
    Schizophr Res; 2007 Jan 30; 89(1-3):232-42. PubMed ID: 17049816
    [Abstract] [Full Text] [Related]

  • 14. Application of the Audio Recorded Cognitive Screen and its relation to functioning in schizophrenia.
    Gelder BM, Loughland CM, Carr VJ, Schofield PW.
    Acta Neuropsychiatr; 2015 Oct 30; 27(5):279-90. PubMed ID: 25959604
    [Abstract] [Full Text] [Related]

  • 15. The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia.
    Dickerson F, Boronow J, Stallings C, Origoni A, Yolken R.
    Schizophr Res; 2007 Jan 30; 89(1-3):173-6. PubMed ID: 17029750
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictors of neuropsychological effort test performance in schizophrenia.
    Morra LF, Gold JM, Sullivan SK, Strauss GP.
    Schizophr Res; 2015 Mar 30; 162(1-3):205-10. PubMed ID: 25583248
    [Abstract] [Full Text] [Related]

  • 18. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S, Seemüller F, Schwarz MJ, Kleindienst N, Stampfer R, Zach J, Born C, Bernhard B, Fast K, Grunze H, Engel RR, Severus E.
    Bipolar Disord; 2007 Mar 30; 9(1-2):63-70. PubMed ID: 17391351
    [Abstract] [Full Text] [Related]

  • 19. TCF4 gene polymorphism is associated with cognition in patients with schizophrenia and healthy controls.
    Hui L, Rao WW, Yu Q, Kou C, Wu JQ, He JC, Ye MJ, Liu JH, Xu XJ, Zheng K, Ruan LN, Liu HY, Hu WM, Shao TN, AngRabanes MB, Soares JC, Zhang XY.
    J Psychiatr Res; 2015 Oct 30; 69():95-101. PubMed ID: 26343600
    [Abstract] [Full Text] [Related]

  • 20. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP, Goldberg R, Bartko JJ, Gold JM.
    Am J Psychiatry; 1999 Dec 30; 156(12):1951-7. PubMed ID: 10588410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.